Posted by Michael Wonder on 21 Aug 2019
Cassiopea announces FDA submission of new drug application for clascoterone 1% cream, the first new mechanism of action for acne in nearly 40 years
20 August 2019 - Cassiopea announced today that it has submitted a new drug application to the U.S. FDA seeking marketing approval for clascoterone cream 1% for the treatment of acne.
Clascoterone cream 1% is under investigation as a first-in-class topical androgen receptor inhibitor for the treatment of acne.
